VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IOSPInnospec Inc.
$82.63$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIOSPFinancials

Innospec Inc. (IOSP) Financials

28Y historyFree accessUpdated daily

Revenue growth remains sluggish at 2.8% as of 2026Q1, while gross margins have compressed significantly from 31.5% in late 2023 to 27.3% in the most recent quarter.

IOSP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98
Sales/Revenue1.79B1.78B1.85B1.95B1.96B1.48B1.19B1.51B1.48B1.31B883.4M1.01B960.9M818.8M776.4M774.4M683.2M598.5M640.5M602.4M532.1M527.7M480.5M462.2M451.5M420.9M422.4M516.8M465M
Revenue Growth %0.25%-3.65%-5.31%-0.76%32.38%24.33%-21.16%2.46%13.02%47.93%-12.73%5.35%17.35%5.46%0.26%13.35%14.15%-6.56%6.32%13.21%0.83%9.82%3.96%2.37%7.27%-0.36%-18.27%11.14%-
Cost of Goods Sold1.3B1.29B1.3B1.36B1.38B1.05B850.4M1.05B1.04B903.5M551.1M666.3M658.9M563.6M540M548M466M409.2M454.1M405M345.4M338.2M271M257.7M257.3M240.2M238.9M309.9M227.2M
COGS % of Revenue-72.31%70.58%69.67%70.12%70.68%71.28%69.19%70.55%69.14%62.38%65.82%68.57%68.83%69.55%70.76%68.21%68.37%70.9%67.23%64.91%64.09%56.4%55.76%56.99%57.07%56.56%59.97%48.86%
Gross Profit490.8M492.4M542.9M591.1M586.7M434.9M342.7M466.2M435M403.3M332.3M346M302M255.2M236.4M226.4M217.2M189.3M186.4M197.4M186.7M189.5M209.5M204.5M194.2M180.7M183.5M206.9M237.8M
Gross Margin %27.41%27.69%29.42%30.33%29.88%29.32%28.72%30.81%29.45%30.86%37.62%34.18%31.43%31.17%30.45%29.24%31.79%31.63%29.1%32.77%35.09%35.91%43.6%44.24%43.01%42.93%43.44%40.03%51.14%
Gross Profit Growth %--9.3%-8.15%0.75%34.9%26.9%-26.49%7.17%7.86%21.37%-3.96%14.57%18.34%7.95%4.42%4.24%14.74%1.56%-5.57%5.73%-1.48%-9.55%2.44%5.3%7.47%-1.53%-11.31%-12.99%-
Operating Expenses346.5M336.1M365M429.5M399.4M302.8M309M316.3M294.4M270.9M234.9M232M191.4M163.1M136.7M174.2M134.1M163.6M137M146.5M150.3M255.9M160.2M91.2M69.7M-41.23M124.8M117.2M102.9M
OpEx % of Revenue-18.9%19.78%22.04%20.34%20.41%25.9%20.9%19.93%20.73%26.59%22.92%19.92%19.92%17.61%22.49%19.63%27.33%21.39%24.32%28.25%48.49%33.34%19.73%15.44%-9.8%29.55%22.68%22.13%
Selling, General & Admin294.3M285.1M314M387.8M360.7M267.2M237M280.9M261M239.5M209.5M206.7M169.2M141.9M117.1M155.9M111.9M142.5M115.2M103.9M99M97.6M93.4M75.7M70M57.6M41.5M44.9M40.1M
SG&A % of Revenue-16.03%17.02%19.9%18.37%18.01%19.86%18.56%17.67%18.33%23.72%20.42%17.61%17.33%15.08%20.13%16.38%23.81%17.99%17.25%18.61%18.5%19.44%16.38%15.5%13.69%9.82%8.69%8.62%
Research & Development51.5M51M47.8M41.7M38.7M37.4M30.9M35.4M33.4M31.4M25.4M25.3M22.2M21.2M19.6M18.3M17.6M16.4M14.8M13.6M11.1M11.2M10.5M5.1M6M5.1M3.1M3.9M3.1M
R&D % of Revenue-2.87%2.59%2.14%1.97%2.52%2.59%2.34%2.26%2.4%2.88%2.5%2.31%2.59%2.52%2.36%2.58%2.74%2.31%2.26%2.09%2.12%2.19%1.1%1.33%1.21%0.73%0.75%0.67%
Other Operating Expenses700K03.2M00-1.8M41.1M000900K01.8M0004.6M4.7M7M29M40.2M147.1M56.3M10.4M-6.3M-103.93M80.2M68.4M59.7M
Operating Income144.3M156.3M177.9M161.6M187.3M132.1M33.7M149.9M133.5M129.7M105.4M156.3M112.5M90.6M98.4M49.6M72.2M20.7M43.6M47.9M31.9M-97.7M40.8M98.3M105M59.3M58.7M89.7M134.9M
Operating Margin %8.06%8.79%9.64%8.29%9.54%8.91%2.82%9.91%9.04%9.93%11.93%15.44%11.71%11.06%12.67%6.4%10.57%3.46%6.81%7.95%6%-18.51%8.49%21.27%23.26%14.09%13.9%17.36%29.01%
Operating Income Growth %--12.14%10.09%-13.72%41.79%291.99%-77.52%12.28%2.93%23.05%-32.57%38.93%24.17%-7.93%98.39%-31.3%248.79%-52.52%-8.98%50.16%132.65%-339.46%-58.49%-6.38%77.07%1.02%-34.56%-33.51%-
EBITDA186.6M205.6M221.4M200.9M227.4M174.8M79.7M200.9M189.2M185.3M143.1M191.5M141.6M111M109.9M64M87.6M39.1M66.6M79.2M59.3M-69M65.2M124.1M137.4M146.5M138.9M158.1M194.6M
EBITDA Margin %10.42%11.56%12%10.31%11.58%11.78%6.68%13.28%12.81%14.18%16.2%18.92%14.74%13.56%14.16%8.26%12.82%6.53%10.4%13.15%11.14%-13.08%13.57%26.85%30.43%34.81%32.88%30.59%41.85%
EBITDA Growth %-12.76%-7.14%10.2%-11.65%30.09%119.32%-60.33%6.18%2.1%29.49%-25.27%35.24%27.57%1%71.72%-26.94%124.04%-41.29%-15.91%33.56%185.94%-205.83%-47.46%-9.68%-6.21%5.47%-12.14%-18.76%-
D&A (Non-Cash Add-back)42.3M49.3M43.5M39.3M40.1M42.7M46M51M55.7M55.6M37.7M35.2M29.1M20.4M11.5M14.4M15.4M18.4M23M31.3M27.4M28.7M24.4M25.8M32.4M87.2M80.2M68.4M59.7M
EBIT125.4M156.3M181.1M161.6M187.3M130.3M41.5M155.2M138.5M136.3M106.3M156.3M114.3M95.1M97M54.1M75.8M24.6M25.3M50.9M36.4M-66.4M50M112.8M124.5M221.93M58.7M89.7M135M
Net Interest Income4.9M9.2M00-1.1M-1.5M-1.8M-4.8M-6.9M-8.2M-3.2M-4M-3.4M-1.9M-1.2M-3.3M-4.6M-6M-5.4M0000000000
Interest Income4.9M9.2M0000000000400K400K600K0001M0000000000
Interest Expense00001.1M1.5M1.8M4.8M6.9M8.2M3.2M4M3.8M2.3M1.8M3.3M4.6M6M6.4M0000000000
Other Income/Expense-10.7M-18.2M-136.7M12.8M-2.7M2.3M6M500K-1.9M-4.3M-2.3M-4M-1.6M2.2M-3.2M3M-1.5M-2.4M-24.7M-200K0-20.4M-7.7M-20.6M-31M-22.6M-23M-14.4M-23.1M
Pretax Income133.6M138.1M41.2M174.4M184.6M134.4M39.7M150.4M131.6M128.1M103.1M152.3M110.9M92.8M95.2M52.6M70.7M18.3M18.8M47.7M31.9M-118.1M31.1M77.1M74M36.7M35.7M75.3M111.9M
Pretax Margin %7.46%7.77%2.23%8.95%9.4%9.06%3.33%9.94%8.91%9.8%11.67%15.04%11.54%11.33%12.26%6.79%10.35%3.06%2.94%7.92%6%-22.38%6.47%16.68%16.39%8.72%8.45%14.57%24.06%
Income Tax19M21.5M5.6M35.3M51.6M41.3M11M38.2M46.6M66.3M21.8M32.8M26.8M15M26.9M3.7M-3M11.9M6.3M18.2M20.4M4.2M20M23.3M23M19.8M17.4M32.7M41.5M
Effective Tax Rate %14.22%15.57%13.59%20.24%27.95%30.73%27.71%25.4%35.41%51.76%21.14%21.54%24.17%16.16%28.26%7.03%-4.24%65.03%33.51%38.16%63.95%-3.56%64.31%30.22%31.08%53.95%48.74%43.43%37.09%
Net Income114.2M116.6M35.6M139.1M133M93.1M28.7M112.2M85M61.8M81.3M119.5M84.1M77.8M68.3M48.9M73.7M6.4M12.5M29.5M11.4M-123.7M6.2M51.8M52.1M5.6M18.3M42.6M70.4M
Net Margin %6.38%6.56%1.93%7.14%6.77%6.28%2.41%7.41%5.76%4.73%9.2%11.8%8.75%9.5%8.8%6.31%10.79%1.07%1.95%4.9%2.14%-23.44%1.29%11.21%11.54%1.33%4.33%8.24%15.14%
Net Income Growth %322.96%227.53%-74.41%4.59%42.86%224.39%-74.42%32%37.54%-23.99%-31.97%42.09%8.1%13.91%39.67%-33.65%1051.56%-48.8%-57.63%158.77%109.22%-2095.16%-88.03%-0.58%830.36%-69.4%-57.04%-39.49%-
Net Income (Continuing)114.6M116.6M35.6M139.1M133M93.1M28.7M112.2M85M61.8M81.3M119.5M84.1M77.8M68.3M48.9M73.7M6.4M12.6M29.6M11.4M-122.3M13.9M54.1M51M16.9M18.3M42.6M70.4M
Discontinued Operations00000000000000000000000000000
Minority Interest7.2M6.8M4.9M2.5M2.4M600K500K400K500K400K300K300K00000000100K300K200K6.6M4.6M5.9M4.5M2.4M0
EPS (Diluted)4.604.671.425.565.323.751.164.543.452.523.334.863.383.222.811.992.970.260.511.190.45-5.000.242.062.080.230.711.532.42
EPS Growth %333.02%228.87%-74.46%4.51%41.87%223.28%-74.45%31.59%36.9%-24.32%-31.48%43.79%4.97%14.59%41.21%-33%1042.31%-49.02%-57.14%164.44%109%-2183.33%-88.35%-0.96%804.35%-67.61%-53.59%-36.78%-
EPS (Basic)-4.691.435.605.373.781.174.583.482.563.394.963.453.292.892.073.100.270.531.230.47-5.000.252.172.210.240.731.542.42
Diluted Shares Outstanding24.84M24.99M25.12M25.02M24.98M24.85M24.78M24.73M24.6M24.49M24.44M24.61M24.88M24.16M23.85M24.57M24.81M24.71M24.39M24.84M25.34M24.74M25.98M25.15M25.11M24.89M26M27.96M29.03M
Basic Shares Outstanding24.78M24.88M24.93M24.85M24.79M24.65M24.56M24.48M24.4M24.15M24M24.11M24.39M23.65M23.19M24.52M23.76M23.64M23.59M23.92M24.14M24.74M24.69M23.87M23.63M23.53M25.16M27.65M29.03M
Dividend Payout Ratio-36.36%108.99%25.23%23.83%30.93%89.2%22.28%25.53%30.1%19.56%12.47%15.93%15.42%68.37%--18.75%19.2%7.46%16.67%-24.19%1.16%1.15%----

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Cyclical End-Market Exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Faces Cyclical Headwinds

According to recent financial disclosures, Innospec's revenue trajectory remains inconsistent, with the most recent quarterly figures showing a modest 2.8% growth rate, yet the broader trend over the last ten quarters reflects persistent volatility and periodic contraction in core specialty chemical and oilfield service demand segments.

The revenue profile suggests a struggle to maintain consistent top-line expansion, likely hampered by the cyclical nature of oilfield services and potential price normalization in fuel additives. Investors should monitor whether the recent return to positive growth in 2026Q1 represents a durable recovery or merely a temporary fluctuation against easier year-over-year comparisons.

Gross Margin Compression Remains Evident

As reported in quarterly income statements, Innospec's gross margin has experienced a noticeable contraction from the 31.5% levels observed in late 2023 to 27.3% in 2026Q1, suggesting that the company is facing challenges in fully offsetting rising input costs through its specialty pricing strategies.

The erosion of gross margins indicates that the company's value-added formulations may be facing increased competitive pressure or that raw material inflation is outpacing the firm's ability to pass costs to customers. This trend warrants further investigation into whether the product mix is shifting toward lower-margin offerings within the fuel specialties division.

Operating Leverage Constrained by Overhead

Based on the provided income statement data, Innospec's operating margin has struggled to scale, fluctuating between 7% and 10% over the last ten quarters, which implies that SG&A and R&D expenses are consuming a significant portion of the gross profit generated by the company's specialty chemical operations.

The lack of meaningful operating leverage suggests that the company's cost structure is relatively rigid, preventing significant margin expansion even when revenue growth is positive. Analysts should consider whether the current level of SG&A spending is necessary to support long-term innovation or if it reflects inefficiencies in the company's mid-sized operational scale.

Net Income Volatility Obscures Performance

Financial filings reveal that Innospec's net income has been subject to significant volatility, highlighted by a substantial net loss in 2024Q4, which suggests that non-operating items or legacy liability adjustments may be periodically distorting the underlying profitability of the core specialty chemical business for shareholders.

The wide variance in net income, particularly when compared to more stable operating income, indicates that investors should focus on adjusted metrics to gauge true operational health. The impact of legacy environmental and pension obligations appears to be a recurring factor that complicates the assessment of the company's sustainable earnings power.

IOSP — Frequently Asked Questions

Quick answers to the most common questions about buying IOSP stock.

What was Innospec Inc.'s (IOSP) revenue in 2025?

For fiscal year 2025, Innospec Inc. (IOSP) reported total revenue of $1.78B. This represents a 282.4% increase compared to $465.0M in 1998.

Is Innospec Inc. (IOSP) profitable?

Innospec Inc. (IOSP) is profitable, generating $116.6M in net income for the fiscal year ending 2025 with a net profit margin of 6.6%.

What is Innospec Inc.'s operating profit margin?

Innospec Inc. (IOSP) reported an operating income of $156.3M, resulting in an operating profit margin of 8.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Innospec Inc.'s gross profit and gross margin?

Innospec Inc. (IOSP) generated $492.4M in gross profit for the year, representing a gross profit margin of 27.7%. This demonstrates the company's core pricing power and production efficiency.